Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseases
about
Methamphetamine-associated psychosis.Manganese-Enhanced Magnetic Resonance Imaging for Detection of Vasoactive Intestinal Peptide Receptor 2 Agonist Therapy in a Model of Parkinson's Disease.Functional proteomic analysis for regulatory T cell surveillance of the HIV-1-infected macrophage.Anti-human α-synuclein N-terminal peptide antibody protects against dopaminergic cell death and ameliorates behavioral deficits in an AAV-α-synuclein rat model of Parkinson's disease.Bone marrow-derived microglia infiltrate into the paraventricular nucleus of chronic psychological stress-loaded mice.Prospects of statins in Parkinson diseaseThe Role of immune and inflammatory mechanisms in ALS.Taking the Perspective that a Depressive State Reflects Inflammation: Implications for the Use of AntidepressantsSelective VIP Receptor Agonists Facilitate Immune Transformation for Dopaminergic Neuroprotection in MPTP-Intoxicated Mice.Antibody-aided clearance of extracellular α-synuclein prevents cell-to-cell aggregate transmission.Pathways towards an effective immunotherapy for Parkinson's diseaseInflammation and adaptive immunity in Parkinson's disease.Parkinson's disease and systemic inflammation.Simvastatin as a Potential Disease-Modifying Therapy for Patients with Parkinson's Disease: Rationale for Clinical Trial, and Current Progress.Non-Native Conformational Isomers of the Catalytic Domain of PCSK9 Induce an Immune Response, Reduce Lipids and Increase LDL Receptor Levels.OX40 Gene and Serum Protein Expression Profiles in Patients with Parkinson's Disease.
P2860
Q24632172-5455C0DD-D987-4FB6-B823-8DE9161CD6D4Q31109638-2BFA1614-F31F-49E0-B8FF-72629809554CQ33721196-AF83694C-ABB3-4E6C-8EA9-DD21574520D5Q35058359-93AA191B-245D-4E1F-89D2-14DB4B12A0B5Q35058650-D1FDA8C4-C244-412A-BBED-F8D987F34A54Q35094028-09721073-8007-4A40-8536-F3DB41080A8AQ35238394-AF8D52C9-505D-49A8-84A0-271DBB7CB612Q36171115-3D41E02F-4910-4307-9EA2-87066762505AQ36373813-4F4726A7-309F-41E5-BA0F-4922AF6ED585Q37117527-7ED0BEBE-E536-4C49-8BF7-93A67231DC3FQ37957125-DD98F766-6D6D-422E-A320-4F708363450BQ37982378-125845FD-2C47-4E15-9EB3-5A2FE174606BQ42651923-F3EE7A53-E183-4377-A643-4C082AA14768Q45201060-7935B128-8044-44BF-AC61-CD4B187F575CQ51766347-DB3B1411-B772-44D5-A525-4207290C9E97Q52596988-7742637E-ECC2-4174-8DA6-ABA14B0A30BE
P2860
Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseases
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Adaptive immune regulation of ...... for neurodegenerative diseases
@ast
Adaptive immune regulation of ...... for neurodegenerative diseases
@en
Adaptive immune regulation of ...... for neurodegenerative diseases
@nl
type
label
Adaptive immune regulation of ...... for neurodegenerative diseases
@ast
Adaptive immune regulation of ...... for neurodegenerative diseases
@en
Adaptive immune regulation of ...... for neurodegenerative diseases
@nl
prefLabel
Adaptive immune regulation of ...... for neurodegenerative diseases
@ast
Adaptive immune regulation of ...... for neurodegenerative diseases
@en
Adaptive immune regulation of ...... for neurodegenerative diseases
@nl
P2093
P2860
P1476
Adaptive immune regulation of ...... for neurodegenerative diseases
@en
P2093
Ashley D Reynolds
David K Stone
Howard E Gendelman
Jessica A L Hutter
Lisa M Kosloski
Michael R Pichler
R Lee Mosley
P2860
P304
P356
10.1111/J.1471-4159.2010.06834.X
P407
P577
2010-05-26T00:00:00Z